ArticleInternational journal of women's health2025
Prevalence of Premenstrual Syndrome (PMS) Among Female Biomedical Students in Kabul, Afghanistan: A Cross-Sectional Study.
Article in International journal of women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Article
- Global Burden of Premenstrual Syndrome and Uterine Fibroids in Women of Reproductive Age (1990-2023) and Projections to 2050: An Analysis of the Global Burden of Disease Study 2023.Health science reports · 2026Article
- Article
- Premenstrual syndrome-related quality of life: associations with ultra-processed food consumption, mindful eating, well-being, and social media addiction in women.BMC women's health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Premenstrual Syndrome (PMS) is a significant public health concern affecting a substantial proportion of women worldwide, with a global prevalence of approximately 47.8%. In Afghanistan, the PMS is prevalent, and the magnitude is unknown. Due to a lack of studies, this is the first study that sheds light on prevalence of PMS. Objective: This study investigates the prevalence and symptoms of PMS among female students in Kabul, Afghanistan. Materials and Methods: This descriptive cross-sectional study was conducted between May and September 2024 on a sample of 285 students. A systematic and stratified random sampling method was employed. Data were collected using a standardized questionnaire and analyzed using SPSS version 26. The chi-square test was performed to assess the association between PMS prevalence and variables such as age and menstrual cycle status. Results: The study achieved a response rate of 84.91%. The participants' age distribution was 39.7% between 18-20 years, 57% between 21-25 years, and 3.3% above 25 years. Most participants were single (87.6%), and 76.9% reported having regular menstrual cycles. The prevalence of PMS was 72.3% based on ICD-10 criteria and 21.1% based on ACOG criteria. The chi-square test indicated no statistically significant association between age groups and PMS prevalence (p-value= 0.151), but significant relationship was observed between menstrual cycle regularity and PMS prevalence (p-value= 0.018). The most frequently reported symptoms were muscle, joint, and back pain (86.8%), fatigue (84.3%), and reduced interest in activities (77.3%). Conclusion: The high prevalence of PMS and its association with irregular menstrual cycles highlight the need for targeted awareness campaigns, culturally sensitive interventions, and improved healthcare access to mitigate its effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.